1. Home
  2. INTR vs IRTC Comparison

INTR vs IRTC Comparison

Compare INTR & IRTC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

INTR

Inter & Co. Inc.

HOLD

Current Price

$5.88

Market Cap

3.4B

Sector

N/A

ML Signal

HOLD

Logo iRhythm Technologies Inc.

IRTC

iRhythm Technologies Inc.

HOLD

Current Price

$114.50

Market Cap

3.9B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
INTR
IRTC
Founded
1994
2006
Country
Brazil
United States
Employees
N/A
N/A
Industry
Medical/Dental Instruments
Sector
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
3.4B
3.9B
IPO Year
2021
2016

Fundamental Metrics

Financial Performance
Metric
INTR
IRTC
Price
$5.88
$114.50
Analyst Decision
Buy
Strong Buy
Analyst Count
2
13
Target Price
$10.00
$197.92
AVG Volume (30 Days)
5.4M
462.5K
Earning Date
05-11-2026
04-30-2026
Dividend Yield
1.51%
N/A
EPS Growth
N/A
61.71
EPS
N/A
N/A
Revenue
N/A
$747,138,000.00
Revenue This Year
$84.07
$19.60
Revenue Next Year
$18.26
$15.94
P/E Ratio
$16.39
N/A
Revenue Growth
N/A
26.24
52 Week Low
$5.92
$112.31
52 Week High
$10.36
$210.01

Technical Indicators

Market Signals
Indicator
INTR
IRTC
Relative Strength Index (RSI) 29.17 42.63
Support Level N/A $112.65
Resistance Level $8.66 $127.50
Average True Range (ATR) 0.39 6.43
MACD -0.16 -0.72
Stochastic Oscillator 5.15 12.08

Price Performance

Historical Comparison
INTR
IRTC

About INTR Inter & Co. Inc.

Inter & Co Inc operates as a digital bank. The company's segment includes Banking & Spending; Investments; Insurance Brokerage; and Inter Shop. It generates maximum revenue from the Banking & Spending segment which comprises a wide range of banking products and services, such as checking accounts, cards, deposits, loans and advances, and other services, which are available to the clients by means of Inter's mobile application.

About IRTC iRhythm Technologies Inc.

iRhythm Holdings Inc is a digital healthcare company that creates trusted solutions that detect, predict, and prevent disease. Its principal business is the design, development, and commercialization of device-based technology to provide ambulatory cardiac monitoring services that it believes allow clinicians to diagnose certain arrhythmias quicker and with greater efficiency than other services that rely on traditional technology. Each Zio System combines an FDA-cleared and CE-marked, wire-free, patch-based, 14-day wearable biosensor that continuously records electrocardiogram (ECG) data with a proprietary, FDA-cleared, CE-marked cloud-based data analytic software to help physicians monitor patients and diagnose arrhythmias.

Share on Social Networks: